IGHE and allergic disease: With PMI the allergists have to deal with molecular mechanisms of allergy and they have to characterize the endotype of any single patient [57, 58] renouncing the idea that a suspected allergic patient should be tested either towards “the most common allergenic sources” only or towards targeted specific IgE based on the patient’s history [59, 60].